Loading…

Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias of Undetermined Significance

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.2893-2894
Main Authors: Xie, Zhuoer, McCullough, Kristen, Lasho, Terra, Fernandez, Jenna A., Finke, Christy, Amundson, Michelle Renee, Laplant, Betsy, Mangaonkar, Abhishek A., Gangat, Naseema, Reichard, Kaaren K., Elliott, Michelle A, Witzig, Thomas E., Patnaik, Mrinal M.M.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-165163